ENTITY
Ensysce Biosciences

Ensysce Biosciences (ENSC US)

22
Analysis
Health Care • United States
Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.
more
bullish•Ensysce Biosciences
•01 Apr 2026 00:00•Issuer-paid

ENSC: Earnings Release Show Positive Momentum

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•22 Jan 2026 01:00•Issuer-paid

ENSC: Expanding Global Footprint for Game Changing Treatments

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•10 Dec 2025 01:00•Issuer-paid

ENSC: Phase 3 Trial Enrolls 1st Patient

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•18 Nov 2025 01:00•Issuer-paid

ENSC: Pipeline Advancement Gets Cash Infusion

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
•21 Sep 2022 08:00•Issuer-paid

Mat-Chem Notes for the Week Ended September 18, 2022

KEY HIGHLIGHTS WTR-CMI last week. Reversing the prior week’s trend, the stock market pulled back last week following the release of disappointing...

Logo
895 Views
Share
x